NCT04332393View on ClinicalTrials.gov

Metformin to Treat Corticosteroids-induced Hyperglycemia

PHASE4CompletedINTERVENTIONAL

Enrollment

187

Participants

Timeline

Start Date

July 5, 2020

Primary Completion Date

July 7, 2024

Study Completion Date

May 5, 2025

Conditions

Pregnancy PretermGlycemic ControlCorticosteroids Induced Hyperglycemia

Interventions

DRUG

Metformin

Metformin tablets according to glycemic control. Initial dose: 425 mg before meals (breakfast, lunch and supper) and 1700 mg around 22:00. Modifications may take place according to glycemic control

Trial Locations (4)

15208

Baruch Padeh Medical center, Poriya, Tiberias

Unknown

Emek medical center, Afula

Galilee medical center, Nahariya

Ziv medical center, Safed

All Listed Sponsors

lead

The Baruch Padeh Medical Center, Poriya

OTHER_GOV

NCT04332393 - Metformin to Treat Corticosteroids-induced Hyperglycemia | Biotech Hunter | Biotech Hunter